Laporan Laba Rugi (TTM)
Laporan Laba Rugi BioMarin Pharmaceutical Inc. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,863 | 1,860 | 1,844 | 1,917 | 1,849 | 1,846 | 1,880 | 1,912 | 2,008 | 2,096 | 2,173 | 2,235 | 2,311 | 2,419 | 2,472 | 2,588 | 2,753 | 2,854 | 2,950 | 3,064 |
| Change (%) | -0.12 | -0.86 | 3.91 | -3.55 | -0.12 | 1.81 | 1.71 | 5.05 | 4.37 | 3.68 | 2.83 | 3.40 | 4.70 | 2.17 | 4.72 | 6.35 | 3.67 | 3.37 | 3.84 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1,138 | 1,152 | 1,168 | 1,176 | 1,101 | 1,099 | 1,108 | 1,101 | 1,114 | 503 | 1,011 | 1,189 | 694 | 532 | 555 | 561 | 971 | 580 | 560 | 558 |
| Change (%) | 1.24 | 1.32 | 0.69 | -6.33 | -0.18 | 0.81 | -0.62 | 1.15 | -54.85 | 100.94 | 17.68 | -41.64 | -23.35 | 4.29 | 1.13 | 72.99 | -40.23 | -3.43 | -0.51 | |
| % of Revenue | 61.11 | 61.94 | 63.31 | 61.34 | 59.57 | 59.54 | 58.96 | 57.61 | 55.47 | 24.00 | 46.51 | 53.23 | 30.04 | 21.99 | 22.45 | 21.68 | 35.27 | 20.33 | 18.99 | 18.20 |
| Gross Operating Profit | 724 | 708 | 677 | 741 | 747 | 747 | 771 | 810 | 894 | 1,593 | 1,162 | 1,045 | 1,616 | 1,887 | 1,917 | 2,027 | 1,782 | 2,274 | 2,390 | 2,506 |
| Change (%) | -2.27 | -4.42 | 9.48 | 0.86 | -0.05 | 3.27 | 5.05 | 10.35 | 78.14 | -27.04 | -10.08 | 54.66 | 16.75 | 1.57 | 5.76 | -12.10 | 27.59 | 5.11 | 4.86 | |
| % of Revenue | 38.89 | 38.06 | 36.69 | 38.66 | 40.43 | 40.46 | 41.04 | 42.39 | 44.53 | 76.00 | 53.49 | 46.77 | 69.96 | 78.01 | 77.55 | 78.32 | 64.73 | 79.67 | 81.01 | 81.80 |
| SG&A | 730 | 738 | 725 | 733 | 737 | 759 | 780 | 792 | 826 | 823 | 847 | 857 | 856 | 892 | 907 | 964 | 1,002 | 913 | 893 | 863 |
| Change (%) | 1.04 | -1.76 | 1.21 | 0.53 | 2.99 | 2.67 | 1.63 | 4.23 | -0.31 | 2.94 | 1.09 | -0.12 | 4.30 | 1.67 | 6.27 | 3.91 | -8.86 | -2.17 | -3.44 | |
| % of Revenue | 39.19 | 39.65 | 39.29 | 38.27 | 39.89 | 41.13 | 41.48 | 41.45 | 41.12 | 39.28 | 39.00 | 38.34 | 37.03 | 36.89 | 36.71 | 37.25 | 36.40 | 32.00 | 30.28 | 28.16 |
| R&D | 650 | 152 | 541 | 747 | 747 | 747 | 391 | 747 | 747 | 747 | ||||||||||
| Change (%) | -76.60 | 38.16 | 0.00 | 0.00 | -47.62 | 91.02 | 0.00 | 0.00 | ||||||||||||
| % of Revenue | 30.99 | 7.00 | 23.39 | 30.87 | 30.21 | 28.85 | 14.21 | 26.18 | 25.33 | 24.39 | ||||||||||
| OpEx | 1,931 | 1,952 | 1,954 | 1,971 | 1,900 | 1,921 | 1,950 | 1,956 | 2,003 | 2,041 | 2,073 | 2,109 | 2,153 | 2,233 | 2,270 | 2,332 | 2,413 | 2,284 | 2,235 | 2,192 |
| Change (%) | 1.08 | 0.11 | 0.86 | -3.58 | 1.06 | 1.53 | 0.30 | 2.39 | 1.94 | 1.55 | 1.74 | 2.08 | 3.74 | 1.63 | 2.73 | 3.48 | -5.34 | -2.15 | -1.93 | |
| % of Revenue | 103.68 | 104.93 | 105.96 | 102.84 | 102.81 | 104.03 | 103.74 | 102.31 | 99.71 | 97.39 | 95.40 | 94.38 | 93.18 | 92.32 | 91.83 | 90.08 | 87.65 | 80.03 | 75.75 | 71.54 |
| Operating Income | -69 | -92 | -110 | -54 | -52 | -74 | -70 | -44 | 6 | 55 | 100 | 126 | 158 | 186 | 202 | 257 | 340 | 570 | 715 | 872 |
| Change (%) | 33.90 | 19.75 | -50.45 | -4.69 | 43.19 | -5.35 | -37.19 | -113.02 | 850.26 | 82.98 | 25.49 | 25.52 | 17.88 | 8.64 | 27.19 | 32.47 | 67.62 | 25.51 | 21.86 | |
| % of Revenue | -3.68 | -4.93 | -5.96 | -2.84 | -2.81 | -4.03 | -3.74 | -2.31 | 0.29 | 2.61 | 4.60 | 5.62 | 6.82 | 7.68 | 8.17 | 9.92 | 12.35 | 19.97 | 24.25 | 28.46 |
| Interest Expense | -31 | -29 | -26 | -22 | -16 | -15 | -15 | -15 | -16 | -16 | -16 | -16 | -15 | -17 | -17 | -17 | -16 | -13 | -12 | -11 |
| Change (%) | -6.93 | -10.61 | -16.15 | -26.07 | -5.56 | 0.01 | 0.27 | 5.26 | -1.36 | -0.64 | -0.66 | -5.71 | 16.63 | -0.90 | -1.05 | -4.77 | -21.75 | -5.40 | -7.47 | |
| % of Revenue | -1.69 | -1.58 | -1.42 | -1.15 | -0.88 | -0.83 | -0.82 | -0.80 | -0.81 | -0.76 | -0.73 | -0.71 | -0.64 | -0.72 | -0.70 | -0.66 | -0.59 | -0.44 | -0.41 | -0.36 |
| Net Income | 852 | 854 | 795 | 837 | 16 | -64 | 39 | 54 | 84 | 142 | 72 | 100 | 147 | 168 | 205 | 257 | 322 | 427 | 524 | 657 |
| Change (%) | 0.24 | -6.90 | 5.30 | -98.10 | -502.59 | -161.40 | 37.42 | 55.19 | 68.70 | -49.41 | 39.62 | 47.03 | 14.03 | 22.55 | 24.89 | 25.61 | 32.45 | 22.73 | 25.46 | |
| % of Revenue | 45.74 | 45.90 | 43.11 | 43.68 | 0.86 | -3.47 | 2.09 | 2.83 | 4.18 | 6.75 | 3.30 | 4.47 | 6.36 | 6.93 | 8.31 | 9.91 | 11.71 | 14.96 | 17.76 | 21.45 |
Source: Capital IQ
